Massachusetts General Hospital, United States
Dr. Adam S. Feldman is a Urologic Oncologist at the Massachusetts General Hospital Department of Urology and Associate Professor of Surgery at Harvard Medical School. He is the co-Director of the Combined Harvard Fellowship Program in Urologic Oncology and Director of Research for the Department of Urology at MGH. He completed his residency in urology in 2006 and subsequently completed his fellowship in urologic oncology in June 2008. Dr. Feldman focuses his clinical practice in the treatment of bladder cancer, prostate cancer, kidney cancer and other genitourinary malignancies. He focuses his research interests on translational and clinical research in bladder, kidney and prostate cancers. He has received a Prostate Cancer Foundation Young Investigator Award for his work in novel biomarkers in prostate cancer and has been awarded a Physician Research Training Award by the Department of Defense. He has received several federally funded, foundation and industry sponsored research grants for his work in biomarker development and metabolomics in genitourinary malignancies.
Thursday, October 30, 2025
08:00 - 09:00 GMT+0
MC-02: De-intensifying Treatment Strategies for Low and Intermediate Risk Disease
Thursday, October 30, 2025
14:10 - 14:20 GMT+0
Saturday, November 1, 2025
14:24 - 14:39 GMT+0